Finding Right Drug Balance for Parkinson’s Patients

Parkinson’s disease is most commonly treated with levodopa, but the benefits wear off as the disease progresses and high doses can result in dyskinesia, which are involuntary and uncontrollable movements. To better understand the underlying reasons behind these effects, researchers created a model of the interactions between levodopa, dopamine, and the basal ganglia, an area of the brain that plays a crucial role in Parkinson’s disease. They discuss their findings in the journal Chaos.

Read more

The CNS Announces a New Addition to its NEUROSURGERY® Publications Suite of Journals

The Congress of Neurological Surgeons (CNS) is pleased to announce the debut of its latest journal, Neurosurgery Open. The goal of Neurosurgery Open is to provide an outlet for the publication of scientific papers dealing with clinical neurosurgery and experimental neurosurgery

Read more

Congress of Neurological Surgeons Hosts 2019 Annual Meeting in San Francisco, October 19–23

Schaumburg, Illinois, August 21, 2019 — The Congress of Neurological Surgeons (CNS) is proud to host its 67th Annual Meeting in San Francisco, California, October 19–23. Each year, thousands of neurosurgeons, advanced practice providers, health care advocates, and other professionals from around the world gather to celebrate and learn about the advances are being made in the field of neurosurgery.

Read more

CNS Publishes Guidelines for Pediatric Myelomeningocele

The Congress of Neurological Surgeons (CNS) has developed an evidence-based guideline for the treatment of patients with myelomeningocele. Executive summaries of the Congress of Neurological Surgeons Systematic Review and Evidence-Based Guidelines for Pediatric Myelomeningocele were published today in Neurosurgery. Full text of the guidelines can also be found on cns.org.

Read more